Navigation Links
Study Shows That Roche's Investigational Drug for Alzheimer's Disease Removes Amyloid Plaques From the Brain
Date:10/10/2011

BASEL, Switzerland, Oct. 10, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.(1)

It is the first time that clinical data has been published for gantenerumab, an investigational compound with a mechanism of action targeted at the early stages of Alzheimer's disease.

Results from Phase I clinical trials and ex vivo studies demonstrated that gantenerumab treatment results in a dose-dependent reduction of brain amyloid, possibly through phagocytosis via brain microglial cells, whereas amyloid load increased in patients receiving placebo treatment.

"These results and especially the rapidity of the effects observed on amyloid removal are very encouraging and pave the way for the development of a novel treatment for Alzheimer's disease," said Luca Santarelli, Global Head of Roche Neuroscience Disease Translational Area. "Our approach is to utilize biomarkers to diagnose and treat the disease at a very early stage before significant damage to the brain has occurred."

Gantenerumab is an investigational fully human anti-amyloid beta monoclonal antibody designed to bind to amyloid plaques in the brain and remove them. It is hoped that this approach will slow progression of the disease, an outcome that cannot be achieved with currently approved treatments.

"Our objective was not only to demonstrate the effects of gantenerumab on brain amyloid, but also to start elucidating its mechanism of action," added Santarelli, "this is extremely important to fully understand the compound's therapeutic potential for Alzheimer's disease."

Since it is known that amyloid accumulate
'/>"/>

SOURCE Roche
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Hernia Publishes a Unique Three Year Pre-Clinical Study of absorbable TIGR® Matrix Surgical Mesh Versus a Permanent Mesh
2. Hologic Announces Six-year Follow-up Results from the MammoSite Targeted Breast Irradiation Registry Study
3. Bioness Inc. Announces Completion of Enrollment in Its FASTEST L300 Study
4. FDA CONSUMER HEALTH INFORMATION -- Foreign Exporters Study Food Safety Law
5. Telik Announces Publication in the Journal Cancer of a Phase 2 Randomized Multicenter Study of Two Extended Dosing Schedules of Oral Ezatiostat in Low to Intermediate-1 Risk Myelodysplastic Syndrome
6. Additional Analysis from Two-Year Sequel Study of QNEXA Featured at The 2011 Annual Scientific Meeting of The Obesity Society
7. Study by Ocala Oncology/The US Oncology Network Shows Use of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Patients Improves Overall Survival
8. Adamas Pharmaceuticals Initiates a Phase 2/3 Clinical Study of ADS-5102 for Parkinsons Disease
9. Published Study Demonstrates the Absolute and Trend Accuracy of Masimo Noninvasive and Continuous Total Hemoglobin (SpHb) Monitoring in Intensive Care Unit Patients
10. To Succeed in Crowded Market, Diabetes Manufacturers Beginning Key Launch Tactics Earlier, Study Says
11. Swype Cold & Flu Shield Significantly Reduces Occurrence of Colds in Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015 /CNW/ - More than fifty years ago, Thalidomide was ... in expectant mothers. Tragically, Thalidomide caused serious and permanent physical ... Support has been provided to survivors over the years ... Canada in 1991 and settlements from drug companies. ... obligation to provide support, we have a clear moral obligation ...
(Date:5/22/2015)... , May 22, 2015  BioLife Solutions, Inc. (NASDAQ: ... proprietary clinical grade hypothermic storage and cryopreservation ... for cells and tissues ("BioLife" or the "Company"), announced that ... MicroCap Conference. The Company is scheduled to ... May 27, 2015 at the Grand Hyatt Hotel in ...
(Date:5/22/2015)... May 22, 2015 Electrophysiologist Kevin Makati, ... traveled to Boston, MA ... 2015 Heart Rhythm Society conference. These scientific sessions ... on the ideas, people and technology that propel ... a hybrid, minimally invasive cardiac operation that combines ...
Breaking Medicine Technology:Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3
... 2011  Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE)("Ampio" or the "Company"), ... previously approved drugs and new molecular entities ("NMEs"), announced ... accredited investors to sell an aggregate approximately 2,220,255 of ... share (the "Shares"), at a price per share of ...
... Radiologic (vRad), a technology-enabled national radiology practice, ... Montgomery Radiology Associates (MRA) have joined its ... Inc. (DII). These former MRA radiologists will ... (PMMC) and join the more than 60 ...
Cached Medicine Technology:Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million 2Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million 3vRad Radiology Alliance Continues to Transform Radiology With Most Recent Practice Partnership 2
(Date:5/25/2015)... 2015 The National Association ... Heather Stanley-Christian as a 2015-2016 inductee into ... is recognized with this prestigious distinction for leadership ... organization exclusively for professional women, boasting more than ... , "I'm pleased to welcome Heather into this ...
(Date:5/25/2015)... 2015 24Hr HomeCare is proud to ... Co-Founder & COO, and Ryan Iwamoto, Co-Founder & CMO, ... The Year® 2015 Awards in Greater Los Angeles. The ... excellence in innovation, financial performance, and a personal commitment ... core of the ongoing success of our organization,” said ...
(Date:5/25/2015)... ProDrop Light Show allows users to now have ability ... click of a mouse. Users have full control over angle of ... Pro X. , ProDrop Light Show gives users 30 fully customizable ... more leaving infinite possibilities all within Final Cut Pro X. , ... users can apply their very own media files or text all ...
(Date:5/25/2015)... May 25, 2015 Decora Preset 60 ... is now available on ‘The Hardware City.’ The product helps ... to set a time and the related electronic device is ... a representative of the company said, “We are glad that ... Now customers can buy Countdown Timer Switch in just a ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 Women’s ... to take pressure measurements in patients’ bladder and urethra. ... usually orders it if they have reported symptoms of ... , Women’s Excellence in Bladder Control is a ... urinary leakage or problems with overall control of their ...
Breaking Medicine News(10 mins):Health News:NAPW Inducts Dr. Heather Stanley-Christian, Systems Chair/Maternal Fetal Medicine at Stroger Hospital, into Its VIP Professional Woman of the Year Circle 2Health News:24Hr HomeCare Co-Founders Named Finalists for EY Entrepreneur of the Year 2015 Awards 2Health News:Developers at Pixel Film Studios Release of ProDrop Light Show for Final Cut Pro X. 2Health News:Leviton's Decora 60 Minute Countdown Timer Available On ‘The Hardware City’ 2
... dental expert notes importance of regular oral care to protect ... Results from a 2008 Gallup-Healthways poll(1) show that 42 percent ... 12 months, even though the American Dental Association recommends having ... percent of all Americans responded that they did not see ...
... and Sustained Pain Relief for up to 48 Hours -- ... - MOUNTAIN VIEW, Calif., May 26 MAP Pharmaceuticals, Inc. ... portion of its first Phase 3 clinical trial evaluating its ... endpoints. Additional endpoints showed that LEVADEX provided rapid and ...
... Inc. (Pink Sheets: FTER), owner and operator of the "A ... that an advertisement for "A Better Tomorrow" will appear on ... May and June.The ad, which can be viewed at ... offers a safe, caring, relaxing place to face addiction head ...
... Veracord™, ( www.veracord.com ), a privately held ... Parasoft® Corporation, a leading provider of automated ... the Parasoft award-winning product offering beyond product ... compliance. Together, Veracord and Parasoft offer clients ...
... is presented at The Association for Research in Vision and ... "Accuracy of Transpalpebral Tonometer Diaton Compared to Goldmann Applanation ... Dr. Mark Latina, the inventor of Selective Laser Trabeculoplasty (SLT). ... ...
... of industries like WLAN networks, telecommunication, wireless security, ... experiments, traffic control & Audio/Video, Pro-cell antenna-related goods ... in the Taipei World Trade Exhibition -- COMPUTEX ... the world, next only to CeBIT in Hannover, ...
Cached Medicine News:Health News:Hispanics Placing Their Oral Health at Risk by Cutting Back on Routine Dental Care 2Health News:Hispanics Placing Their Oral Health at Risk by Cutting Back on Routine Dental Care 3Health News:MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints 2Health News:MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints 3Health News:MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints 4Health News:MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints 5Health News:MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints 6Health News:MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints 7Health News:Veracord and Parasoft Partner to Improve Compliance and Reduce Cost 2Health News:Veracord and Parasoft Partner to Improve Compliance and Reduce Cost 3Health News:Thumbs Up at ARVO for Diaton Tonometer - New Through Eyelid Glaucoma Test Clinical Study Presented, Results as Accurate as Gold Standard 2Health News:Thumbs Up at ARVO for Diaton Tonometer - New Through Eyelid Glaucoma Test Clinical Study Presented, Results as Accurate as Gold Standard 3Health News:Pro-cell Announces a Knock at the Door of Emerging Markets 2Health News:Pro-cell Announces a Knock at the Door of Emerging Markets 3Health News:Pro-cell Announces a Knock at the Door of Emerging Markets 4
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: